home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Shareware Overload Trio 2
/
Shareware Overload Trio Volume 2 (Chestnut CD-ROM).ISO
/
dir26
/
med9410n.zip
/
M94A2662.TXT
< prev
next >
Wrap
Text File
|
1994-10-25
|
2KB
|
37 lines
Document 2662
DOCN M94A2662
TI HIV testing sexually abused children: reducing uncertain clinical
decision-making.
DT 9412
AU Durfee M; Gellert GA; Berkowitz C; LA Dept Health, CA 90012.
SO Int Conf AIDS. 1994 Aug 7-12;10(1):253 (abstract no. PB0443). Unique
Identifier : AIDSLINE ICA10/94369913
AB OBJECTIVE: To review the existing literature in search of guidelines for
deciding when to test the sexually abused child for HIV. METHODS:
Clinicians who care for sexually abused children are faced with
considerable difficulties in determining whether or not to test specific
children for HIV antibody. Data on this issue must be collected
prospectively to demonstrate the frequency with which seroconversion
follows abuse, stratified by variables specific to abuse such as type
and duration of assault. No current report providing these data can be
found in the literature. Thus definitive guidelines for HIV antibody
testing of sexually abused children must be derived from an incomplete
database, and physicians must make the critical test decision absent
data on risk of HIV transmission. We reviewed a study of 28 children
infected with HIV from abuse. RESULTS: Using situational and
sociodemographic data on 28 children infected with HIV having no other
risk factors, this discussion willarticulate strategies that may assist
the clinician in deciding when and when not to test sexually abused
children for HIV antibody, including perpetrator serostatus and
behavioral profile, co-existence of other STDs, and other factors.
CONCLUSION: Guidelines for test decision-making guidelines, short of
universal screening of all sexually abused children, may be derived from
existing data and can be more systematically applied by clinicians.
DE *AIDS Serodiagnosis Child Child Abuse, Sexual/*EPIDEMIOLOGY Human
HIV Seropositivity/DIAGNOSIS/EPIDEMIOLOGY/*TRANSMISSION HIV
Seroprevalence Risk Factors United States MEETING ABSTRACT
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).